Label: GOLD BOND ULTIMATE PSORIASIS RELIEF CREAM- salicylic acid lotion

  • NDC Code(s): 41167-0412-2, 41167-0412-5, 41167-0412-6
  • Packager: Chattem, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated January 10, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Gold Bond Ultimate 
    Multi-Symptom Psoriasis Relief Cream

    Drug Facts

  • Active ingredient

    Salicylic acid 3%

  • Purposes

    Psoriasis, Seborrheic Dermatitis

  • Uses

    For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence

  • Warnings

    For external use only

    Ask a doctor before use if

    • condition covers a large area of the body

    When using this product

    • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

    Stop use and ask a doctor if

    • condition worsens or does not improve after regular use of this product as directed

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center immediately.

  • Directions

    Apply to affected areas one to four times daily or as directed by a doctor

  • Inactive ingredients

    water, hydroxyethyl urea, petrolatum, aminomethyl propanol, glycerin, dimethicone, gluconolactone, steareth-21, jojoba esters, glyceryl stearate, stearyl alcohol, aloe barbadensis leaf juice, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, butyrospermum parkii (shea) butter extract, methyl gluceth-20, 7-dehydrocholesterol, bisabolol, ceteareth-25, zea mays (corn) oil, zingiber officinale (ginger) root extract, ceramide NP, hydrolyzed jojoba esters, cetearyl alcohol, stearamidopropyl PG-dimonium chloride phosphate, magnesium ascorbyl phosphate, panthenol, tocopheryl acetate, ceramide EOP, pentylene glycol, ceramide EOS, bis-lauryl cocaminopropylamine/HDI/PEG-100 copolymer, cholesterol, propylene glycol, caprooyl phytosphingosine, polysorbate 60, ceramide NS, cetyl alcohol, isohexadecane, ethylhexylglycerin, 4-t-butylcyclohexanol, ceramide AP, EDTA, behenic acid, butylene glycol, caprooyl sphingosine, methylparaben, tocopherol

  • PRINCIPAL DISPLAY PANEL

    GOLD BOND
    ULTIMATE
    Multi-Symptom
    Psoriasis
    Relief Cream
    Net wT 4 oz (113 g)

    PRINCIPAL DISPLAY PANEL GOLD BOND ULTIMATE Multi-Symptom Psoriasis Relief Cream Net wT 4 oz (113 g)

  • INGREDIENTS AND APPEARANCE
    GOLD BOND ULTIMATE PSORIASIS RELIEF CREAM 
    salicylic acid lotion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-0412
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID3 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    HYDROXYETHYL UREA (UNII: MBQ7DDQ7AR)  
    PETROLATUM (UNII: 4T6H12BN9U)  
    AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    GLUCONOLACTONE (UNII: WQ29KQ9POT)  
    STEARETH-21 (UNII: 53J3F32P58)  
    HYDROGENATED JOJOBA OIL, RANDOMIZED (UNII: Q47ST02F58)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) (UNII: 86FQE96TZ4)  
    SHEA BUTTER (UNII: K49155WL9Y)  
    METHYL GLUCETH-20 (UNII: J3QD0LD11P)  
    7-DEHYDROCHOLESTEROL (UNII: BK1IU07GKF)  
    LEVOMENOL (UNII: 24WE03BX2T)  
    CETEARETH-25 (UNII: 8FA93U5T67)  
    CORN OIL (UNII: 8470G57WFM)  
    GINGER (UNII: C5529G5JPQ)  
    CERAMIDE 3 (UNII: 4370DF050B)  
    HYDROLYZED JOJOBA ESTERS (ACID FORM) (UNII: UDR641JW8W)  
    CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
    STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE (UNII: W6000VEI5Y)  
    MAGNESIUM ASCORBYL PHOSPHATE (UNII: 0R822556M5)  
    PANTHENOL (UNII: WV9CM0O67Z)  
    ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    CERAMIDE 1 (UNII: 5THT33P7X7)  
    PENTYLENE GLYCOL (UNII: 50C1307PZG)  
    CERAMIDE EOS (UNII: CR0J8RN66K)  
    CHOLESTEROL (UNII: 97C5T2UQ7J)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    POLYSORBATE 60 (UNII: CAL22UVI4M)  
    CERAMIDE 2 (UNII: C04977SRJ5)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    ISOHEXADECANE (UNII: 918X1OUF1E)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    4-TERT-BUTYLCYCLOHEXANOL (UNII: K0H1405S9C)  
    CERAMIDE 6 II (UNII: F1X8L2B00J)  
    EDETIC ACID (UNII: 9G34HU7RV0)  
    BEHENIC ACID (UNII: H390488X0A)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    N-HEXANOYLSPHINGOSINE (UNII: 038753E78J)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:41167-0412-221 g in 1 TUBE; Type 0: Not a Combination Product08/01/2016
    2NDC:41167-0412-5113 g in 1 TUBE; Type 0: Not a Combination Product08/01/2016
    3NDC:41167-0412-699 g in 1 TUBE; Type 0: Not a Combination Product01/01/201809/01/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM03208/01/2016
    Labeler - Chattem, Inc. (003336013)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!